Redmile Group, LLC Amicus Therapeutics, Inc. Transaction History

Redmile Group, LLC

  • $908 Million
  • Q3 2025

A detailed history of Redmile Group, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 777,178 shares of FOLD stock, worth $7.37 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
777,178
Previous 1,188,998 34.64%
Holding current value
$7.37 Million
Previous $6.81 Million 10.1%
% of portfolio
0.67%
Previous 0.83%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$5.84 - $8.57 $2.41 Million - $3.53 Million
-411,820 Reduced 34.64%
777,178 $6.12 Million
Q2 2025

Aug 14, 2025
SELL
$5.64 - $8.0 $47.1 Million - $66.8 Million
-8,344,671 Reduced 87.53%
1,188,998 $6.81 Million
Q1 2025

May 15, 2025
BUY
$8.16 - $9.85 $20.2 Million - $24.4 Million
2,478,779 Added 35.14%
9,533,669 $77.8 Million
Q4 2024

Feb 14, 2025
SELL
$9.36 - $12.01 $11.2 Million - $14.3 Million
-1,191,702 Reduced 14.45%
7,054,890 $66.5 Million
Q3 2024

Nov 14, 2024
SELL
$9.55 - $12.09 $22.4 Million - $28.4 Million
-2,348,497 Reduced 22.17%
8,246,592 $88.1 Million
Q2 2024

Aug 14, 2024
SELL
$9.04 - $11.75 $24.1 Million - $31.3 Million
-2,662,197 Reduced 20.08%
10,595,089 $105 Million
Q1 2024

May 15, 2024
SELL
$11.43 - $14.24 $18 Million - $22.4 Million
-1,571,035 Reduced 10.59%
13,257,286 $156 Million
Q4 2023

Feb 14, 2024
SELL
$9.97 - $14.52 $47.2 Million - $68.8 Million
-4,738,640 Reduced 24.22%
14,828,321 $210 Million
Q2 2023

Aug 14, 2023
BUY
$10.72 - $13.3 $13.1 Million - $16.2 Million
1,220,100 Added 6.65%
19,566,961 $246 Million
Q1 2023

May 15, 2023
SELL
$10.91 - $13.54 $20.8 Million - $25.8 Million
-1,902,928 Reduced 9.4%
18,346,861 $203 Million
Q4 2022

Feb 14, 2023
SELL
$9.89 - $12.7 $14.5 Million - $18.7 Million
-1,469,402 Reduced 6.77%
20,249,789 $247 Million
Q3 2022

Nov 14, 2022
SELL
$9.82 - $12.75 $4.32 Million - $5.61 Million
-439,700 Reduced 1.98%
21,719,191 $227 Million
Q2 2022

Aug 15, 2022
SELL
$6.23 - $11.12 $1.06 Million - $1.9 Million
-170,495 Reduced 0.76%
22,158,891 $238 Million
Q1 2022

May 16, 2022
SELL
$7.89 - $12.48 $3.05 Million - $4.83 Million
-386,700 Reduced 1.7%
22,329,386 $211 Million
Q4 2021

Feb 14, 2022
BUY
$9.82 - $12.44 $18.8 Million - $23.8 Million
1,916,783 Added 9.22%
22,716,086 $262 Million
Q2 2021

Aug 16, 2021
SELL
$8.71 - $10.72 $2.74 Million - $3.37 Million
-314,811 Reduced 1.49%
20,799,303 $201 Million
Q1 2021

May 17, 2021
BUY
$9.2 - $23.86 $4.54 Million - $11.8 Million
493,624 Added 2.39%
21,114,114 $209 Million
Q4 2020

Feb 16, 2021
SELL
$13.47 - $24.89 $33.1 Million - $61.1 Million
-2,455,317 Reduced 10.64%
20,620,490 $476 Million
Q3 2020

Nov 16, 2020
SELL
$12.89 - $15.89 $24.1 Million - $29.7 Million
-1,868,888 Reduced 7.49%
23,075,807 $326 Million
Q2 2020

Aug 14, 2020
SELL
$8.86 - $15.69 $2.1 Million - $3.72 Million
-236,805 Reduced 0.94%
24,944,695 $376 Million
Q1 2020

May 15, 2020
SELL
$6.63 - $11.16 $188,716 - $317,658
-28,464 Reduced 0.11%
25,181,500 $233 Million
Q4 2019

Feb 14, 2020
BUY
$7.48 - $10.75 $18.1 Million - $26 Million
2,419,830 Added 10.62%
25,209,964 $246 Million
Q3 2019

Nov 14, 2019
SELL
$8.02 - $13.25 $20,050 - $33,125
-2,500 Reduced 0.01%
22,790,134 $183 Million
Q2 2019

Aug 14, 2019
BUY
$10.96 - $14.4 $34.8 Million - $45.7 Million
3,176,572 Added 16.19%
22,792,634 $284 Million
Q1 2019

May 15, 2019
BUY
$10.04 - $13.92 $113 Million - $157 Million
11,292,845 Added 135.68%
19,616,062 $267 Million
Q4 2018

Feb 14, 2019
SELL
$8.38 - $13.44 $665,372 - $1.07 Million
-79,400 Reduced 0.94%
8,323,217 $79.7 Million
Q3 2018

Nov 14, 2018
SELL
$11.6 - $16.54 $24.5 Million - $34.9 Million
-2,109,115 Reduced 20.06%
8,402,617 $102 Million
Q2 2018

Aug 14, 2018
SELL
$13.13 - $17.09 $2.98 Million - $3.88 Million
-226,926 Reduced 2.11%
10,511,732 $164 Million
Q1 2018

May 15, 2018
BUY
$13.76 - $17.12 $9.81 Million - $12.2 Million
712,888 Added 7.11%
10,738,658 $0
Q4 2017

Feb 14, 2018
SELL
$12.51 - $16.24 $12.3 Million - $16 Million
-986,791 Reduced 8.96%
10,025,770 $144 Million
Q3 2017

Nov 14, 2017
BUY
$11.74 - $15.78 $129 Million - $174 Million
11,012,561
11,012,561 $166 Million

Others Institutions Holding FOLD

# of Institutions
323
Shares Held
323M
Call Options Held
1.09M
Put Options Held
1.04M
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.66B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email